FindTrial
Sign In

Clinical study of YangHuang syndrome of Jaundice

Methodology for systematic analysis of in vivo efficacy material base of traditional Chinese medicine--Chinmedomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-16008712
Enrollment
Unknown
Registered
2016-06-24
Start date
2016-04-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

YangHuang syndrome of Jaundice

Interventions

Case series:None

Sponsors

The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 25 and 80 years old; (2) Informed consent document has been signed; (3) Diagnosis Standard is consistent with YangHuang syndrome in Chinese medicine.

Exclusion criteria

Exclusion criteria: (1) In pregnant and lactating women; (2) the patients who is participating in other clinical trials or the information is not complete; (3) there are severe mental and primary diseases such as kidney and hematopoietic system disease.

Design outcomes

Primary

MeasureTime frame
Metabonomics;—

Contacts

Public ContactWang Xijun

Heilongjiang University of Chinese Medicine

xijunwangls@126.com+86 13339512688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026